1,355 pharmaceutical and medication recalls tracked. Stay informed about FDA drug safety alerts, prescription medications, over-the-counter drugs, and dietary supplements.
Looking for a specific drug? Use the search page to find recalls by medication name, manufacturer, or NDC number.
Asteria Health recalled 670 testosterone pellets on January 26, 2026, due to potential metal particulate contamination. Consumers and healthcare providers must stop using the product immediately. The recall affects all units distributed nationwide in the United States.
Philips Medical Systems recalled 5,136 Azurion 7 M20 systems on January 26, 2026. The devices may move unexpectedly when the Reset Geometry button is pressed, posing a danger to patients and healthcare providers. Consumers should stop using the devices immediately and contact the manufacturer for instructions.
Philips Medical Systems Nederland B.V. recalled 802 Azurion 3 M15 systems on January 26, 2026. The systems may move unexpectedly, posing a risk to patients and healthcare providers. Consumers should stop using the device immediately and follow recall instructions.
Iristar recalled Minoxidil Spray Bottles on January 22, 2026, due to a serious poisoning risk to children. The product fails to meet child-resistant packaging standards mandated by the Poison Prevention Packaging Act. Consumers should stop using the product immediately and secure it out of children's reach.
Thrasio recalled Angry Orange Enzyme Stain Removers on January 22, 2026. The products may contain the bacteria Pseudomonas aeruginosa, posing serious health risks. Consumers should stop using the product and seek a refund immediately.
Unichem Pharmaceuticals recalled Bisoprolol Fumarate and Hydrochlorothiazide tablets on January 21, 2026. The recall affects tablets that do not meet impurity specifications for N-Nitroso Bisoprolol. Consumers should stop using the product and contact their healthcare provider immediately.
Unichem Pharmaceuticals recalled 60,000 bottles of Doxazosin Tablets on January 21, 2026. The tablets were imprinted with the wrong ID, posing a serious risk to consumers. Healthcare providers and users should stop using the product immediately.
Specialty Process Labs recalled 58 grams of Thyroid, USP due to subpotency. The recall affects products distributed nationwide. Consumers should stop using the drug immediately and contact their healthcare provider.
Ruahouine recalled its Hair Growth Serum on January 15, 2026, due to a poisoning hazard. The product lacks child-resistant packaging, violating safety standards. This poses a risk of serious injury or death if ingested by children.
RootStim recalled Beard Growth Serum on January 15, 2026, due to inadequate child-resistant packaging. The product poses a serious poisoning risk to children. Consumers should stop using it immediately and secure it out of reach.
Greenstone LLC recalled 3,456 cartons of methylprednisolone tablets on January 15, 2026. The recall follows reports of incorrect dosing information due to misapplied blister foil. Consumers should stop using the product immediately and contact their healthcare provider.
KVK-Tech Inc. recalled 31,676 packages of Oxycodone Hydrochloride Tablets on January 14, 2026. Defective seals may cause tablets to fall out, posing a health risk. Customers should stop using the product immediately and seek guidance from healthcare providers.
Laerdal Medical recalled 1,202 Compact Suction Units on January 13, 2026. The recall affects models LCSU 4, 800 ml and LCSU 4, 300 ml due to excessive electromagnetic noise. Patients and healthcare providers must stop using the devices immediately.
Rising Pharmaceuticals recalled 4,212 bottles of Furosemide Tablets on January 10, 2026. The recall stems from the discovery of a foreign substance in the medication. Consumers should stop using the product immediately and seek guidance from their healthcare provider.
FUJIFILM Healthcare Americas recalled 16 units of the CH-200 X-ray high-voltage generator on January 9, 2026. The electromagnetic contactors may weld, potentially causing overheating and smoke. The recall affects units distributed nationwide in various states including California and Florida.
Maquet Cardiopulmonary Gmbh recalled 3,050 Venous Bubble Sensors on January 9, 2026. Internal investigations revealed issues with the durability of the connecting cable. Excessive bending can lead to device failure, posing a risk to patient safety.
Olympus Corporation of the Americas recalled 886 units of its Disposable Triple Lumen Sphincterotome on January 7, 2026. The recall follows reports that devices not properly thermoformed could deform and lose performance. Patients and healthcare providers should stop using the device immediately.
Olympus Corporation of the Americas recalled 136,037 Single Use 3-Lumen Sphincterotome V devices on January 7, 2026. The recall affects devices that did not undergo proper thermoforming, risking deformation and loss of performance. Healthcare providers and patients must stop using the devices immediately.
Olympus Corporation of the Americas recalled 1,490 units of its Disposable Triple Lumen Sphincterotome on January 7, 2026. The devices may deform due to improper thermoforming, risking performance failure. Healthcare providers should immediately stop using these devices and follow recall instructions.
Olympus Corporation of the Americas recalled 7,689 Disposable Triple Lumen Sphincterotomes on January 7, 2026. The devices may deform due to inadequate thermoforming, risking performance failure during medical procedures. Healthcare providers must stop using these devices immediately and follow recall instructions.
Olympus Corporation of the Americas recalled 30,489 units of the Single Use 3-Lumen Sphincterotome V on January 7, 2026. The recall stems from devices that failed to undergo proper thermoforming, risking deformation and performance loss. Healthcare providers and patients must stop using the device immediately.
Olympus Corporation recalled 4,183 units of the Single Use 3-Lumen Sphincterotome V on January 7, 2026. Devices may deform and lose performance due to inadequate thermoforming. Healthcare providers should immediately stop using the affected products and follow recall instructions.
Olympus Corporation of the Americas recalled 125 units of its Disposable Triple Lumen Sphincterotome on January 7, 2026. The recall affects devices that did not undergo proper thermoforming, risking deformation and performance loss. Healthcare providers must stop using these devices immediately.
CleverCut recalled 72,023 Single Use 3-Lumen Sphincterotome V devices on January 7, 2026. The devices may deform and lose performance due to a manufacturing issue. Healthcare providers and patients must stop using these instruments immediately.
Receive immediate notifications when medications you care about are recalled. Stay safe with timely FDA drug safety alerts.